Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

18.75
Delayed Data
As of Jul 31
 +0.61 / +3.36%
Today’s Change
12.90
Today|||52-Week Range
28.29
-60.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$446.9M

Company Description

aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler in 2005 and is headquartered in San Diego, CA.

Contact Information

aTyr Pharma, Inc.
3545 John Hopkins Court
San Diego California 92121
P:(858) 731-8389
Investor Relations:

Employees

Shareholders

Mutual fund holders6.89%
Individual stakeholders45.54%
Other institutional11.77%

Top Executives

John D. MendleinExecutive Chairman & Chief Executive Officer
Kelly BlackburnVice President-Clinical Affairs
David M. WeinerChief Medical Officer
John C. McKewVice President-Research
Ying J. BuechlerDirector-Protein Services